Dimethyl fumarate Mylan Euroopan unioni - suomi - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Euroopan unioni - suomi - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Euroopan unioni - suomi - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Euroopan unioni - suomi - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Euroopan unioni - suomi - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Ocutifex 0.25 mg/ml silmätipat, liuos, kerta-annospakkaus Suomi - suomi - Fimea (Suomen lääkevirasto)

ocutifex 0.25 mg/ml silmätipat, liuos, kerta-annospakkaus

pharma stulln gmbh - ketotifen hydrogen fumarate - silmätipat, liuos, kerta-annospakkaus - 0.25 mg/ml - ketotifeeni

Zaditen 0.25 mg/ml silmätipat, liuos, kerta-annospakkaus Suomi - suomi - Fimea (Suomen lääkevirasto)

zaditen 0.25 mg/ml silmätipat, liuos, kerta-annospakkaus

laboratoires thea - ketotifen fumarate - silmätipat, liuos, kerta-annospakkaus - 0.25 mg/ml - ketotifeeni

Zaditen 0.25 mg/ml silmätipat, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

zaditen 0.25 mg/ml silmätipat, liuos

laboratoires thea - ketotifen fumarate - silmätipat, liuos - 0.25 mg/ml - ketotifeeni

Vumerity Euroopan unioni - suomi - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

MARATOOPI 15 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

maratoopi 15 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - topiramatum - tabletti, kalvopäällysteinen - 15 mg - topiramaatti